Tracey Candelora
Adult Health · Pembroke Pines, FLNPI 1689754558
Payments from drug & device makers
Across 84 payments — averaging $48.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$683
- Daiichi Sankyo Inc.$665
- Jazz Pharmaceuticals Inc.$483
- E.r. Squibb & Sons, L.L.C.$254
- Genentech USA, Inc.$208
- Exelixis Inc.$161
- plus $2K from 21 others
What the payments were for
- Food & beverage$3,87895%
- Education$1995%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 23 | $683 |
| Daiichi Sankyo Inc. | 12 | $665 |
| Jazz Pharmaceuticals Inc. | 6 | $483 |
| E.r. Squibb & Sons, L.L.C. | 2 | $254 |
| Genentech USA, Inc. | 2 | $208 |
| Exelixis Inc. | 5 | $161 |
| Novartis | 9 | $159 |
| AstraZeneca | 2 | $143 |
| Beigene USA, Inc. | 1 | $125 |
| Gilead | 1 | $125 |
| AbbVie | 1 | $125 |
| GSK | 1 | $125 |
| Bayer | 2 | $118 |
| Caris MPI, Inc. | 2 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $104 |
| Incyte Corporation | 1 | $100 |
| Lilly USA, LLC | 1 | $90 |
| Bristol Myers Squibb | 1 | $81 |
| Clovis Oncology, Inc. | 2 | $42 |
| Amgen | 2 | $36 |
| Tempus AI, Inc | 1 | $28 |
| Blueprint Medicines Corporation | 1 | $21 |
| G1 Therapeutics, Inc. | 1 | $20 |
| Astellas Pharma US Inc | 1 | $20 |
| Deciphera Pharmaceuticals Inc. | 1 | $19 |
| Ipsen Biopharmaceuticals, Inc | 1 | $19 |
| Seagen Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,077 in reported general payments places this provider in the 85th percentile of 2,237 adult health providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OrgovyxRelugolix | 15 | $34,046 |
| EliquisApixaban | 23 | $18,578 |
| Hydroxyurea | 43 | $1,079 |
| Ondansetron OdtOndansetron | 20 | $653 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 13 | $147 |
| Gabapentin | 17 | $87 |
| Prednisone | 14 | $53 |
Paid to pharmacies, not to this prescriber.
Other adult health in Pembroke Pines
- Patricia PagnottaMaitland$441K
- Carly KoelschSarasota$265K
- Norma SolisMiami$150K
- Ashley PontenbergWinter Park$136K
- Jeffrey HernandezMiami$122K
- Jamie JohnsonTampa$58K
- Jessica MangesClearwater$52K
- Sita SwamyOrlando$49K
- Alejandro Dela CruzOrlando$44K
- Cynthia OteroMaitland$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.